| Title | Psychopharmacology of ADHD in pediatrics: current advances and issues. | | Author(s) | Greydanus DE, Nazeer A, Patel DR | | Institution | Michigan State University College of Human Medicine, Michigan State University/Kalamazoo Center for Medical Studies, Kalamazoo, MI, USA. | | Source | Neuropsychiatr Dis Treat 2009.:171-81. | | Abstract | Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder found in 3% to 8% of children and adolescents. An important part of ADHD management is psychopharmacology, which includes stimulants, norepinephrine reuptake inhibitors, alpha-2 agonists, and antidepressants. Medications with the best evidence-based support for ADHD management are the stimulants methylphenidate and amphetamine. A number of newer, long-acting stimulants are now available and a number of new medications are considered that are under current research. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19557112 |
|
